Work

Toward the development of a protein-based group B Streptococcus vaccine

Year: 2022

Type: article

Abstract: Clinical trials of protein-based vaccines to prevent Group B streptococcal infections are underway. In this issue of Cell Reports Medicine , Pawlowski et al. 1 provide an extensive characterization of the immune response generated by the recently tested GBS-NN vaccine.

Source: Cell Reports Medicine

DOI: 10.1016/j.xcrm.2022.100536

Authors: Kristen Dominguez, Tara M. Randis

Institution: University of South Florida

Language: English

Topic: Neonatal and Maternal Infections

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,200